Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Abstract Drug repurposing is an invaluable strategy to identify new uses for existing drug therapies that overcome many of the time and financial costs associated with novel drug development. The COVID-19 pandemic has driven an unprecedented surge in the development and use of bioinformatic tools to...
Main Authors: | Ali S. Imami, Robert E. McCullumsmith, Sinead M. O’Donovan |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-11-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-021-01724-w |
Similar Items
-
Identification of candidate repurposable drugs to combat COVID-19 using a signature-based approach
by: Sinead M. O’Donovan, et al.
Published: (2021-02-01) -
Adenosine Receptor mRNA Expression in Frontal Cortical Neurons in Schizophrenia
by: Smita Sahay, et al.
Published: (2023-12-01) -
Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
by: Liliana Rodrigues, et al.
Published: (2022-04-01) -
Dr. Lance Dworkin: A Pioneer in Medicine and Research
by: Robert McCullumsmith
Published: (2023-12-01) -
Activity of Protein Kinase A in the Frontal Cortex in Schizophrenia
by: Smita Sahay, et al.
Published: (2023-12-01)